Literature DB >> 17264103

Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation.

O P Milling Smith1, H N Jabbour, H O D Critchley.   

Abstract

BACKGROUND: Although the mechanisms underlying the causes of heavy menstrual blood loss (MBL) remain to be elucidated, prostaglandins have been previously implicated. This study was initiated to elucidate a pattern of expression of the various components of the cyclooxygenase (COX)-prostaglandin signalling pathways present in the endometrium of women with normal and heavy MBLs.
METHODS: Endometrial biopsies were collected at different stages of the menstrual cycle from women who underwent measurement of MBL. Tissue was divided for either examination of gene expression by quantitative RT-PCR analysis or in vitro culture experimentation.
RESULTS: Analysis of gene expression demonstrated a significant elevation in expression of COX-1 and COX-2 mRNA in endometrium obtained from women with heavy MBL when compared with endometrium obtained from women with normal MBL. Tissue culture with PGE(2) stimulation caused a significantly elevated production of cyclic AMP (cAMP) by endometrium of women with heavy MBL when compared with normal MBL. Expression of phosphodiesterase 4B, an enzyme involved in cAMP breakdown, was reduced in these same endometrial samples obtained from women with heavy MBL.
CONCLUSIONS: These data identify the E series prostaglandin receptors and their signalling pathways as potential therapeutic targets in the treatment of heavy menstruation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264103      PMCID: PMC2694303          DOI: 10.1093/humrep/del503

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  37 in total

1.  DETERMINATION OF MENSTRUAL BLOOD LOSS.

Authors:  L HALLBERG; L NILSSON
Journal:  Scand J Clin Lab Invest       Date:  1964       Impact factor: 1.713

2.  A plain-muscle stimulant in the menstruum.

Authors:  V R PICKLES
Journal:  Nature       Date:  1957-11-30       Impact factor: 49.962

Review 3.  Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.

Authors:  Tilo Grosser; Susanne Fries; Garret A FitzGerald
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

4.  Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002-3.

Authors:  Peter C Reid; Faizah Mukri
Journal:  BMJ       Date:  2005-02-04

Review 5.  Prostaglandins and menstruation.

Authors:  D T Baird; S T Cameron; H O Critchley; T A Drudy; A Howe; R L Jones; R G Lea; R W Kelly
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1996-12       Impact factor: 2.435

Review 6.  Cyclooxygenases 1 and 2.

Authors:  J R Vane; Y S Bakhle; R M Botting
Journal:  Annu Rev Pharmacol Toxicol       Date:  1998       Impact factor: 13.820

Review 7.  Co-expression of prostaglandin receptors with opposite effects: a model for homeostatic control of autocrine and paracrine signaling.

Authors:  B Ashby
Journal:  Biochem Pharmacol       Date:  1998-02-01       Impact factor: 5.858

Review 8.  PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression.

Authors:  María Jesús Sanz; Julio Cortijo; Esteban J Morcillo
Journal:  Pharmacol Ther       Date:  2005-02-25       Impact factor: 12.310

9.  Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation.

Authors:  J Kooy; N H Taylor; D L Healy; P A Rogers
Journal:  Hum Reprod       Date:  1996-05       Impact factor: 6.918

10.  Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid.

Authors:  J Bonnar; B L Sheppard
Journal:  BMJ       Date:  1996-09-07
View more
  19 in total

Review 1.  Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway.

Authors:  Diane M Duffy
Journal:  Hum Reprod Update       Date:  2015-05-29       Impact factor: 15.610

2.  Endocannabinoid regulation in human endometrium across the menstrual cycle.

Authors:  Jessica G Scotchie; Ricardo F Savaris; Caitlin E Martin; Steven L Young
Journal:  Reprod Sci       Date:  2014-05-12       Impact factor: 3.060

Review 3.  MicroRNA signature and regulatory functions in the endometrium during normal and disease states.

Authors:  Qun Pan; Nasser Chegini
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

4.  Hormonal Profiles of Menstrual Bleeding Patterns During the Luteal-Follicular Transition.

Authors:  Melanie H Jacobson; Penelope P Howards; James S Kesner; Juliana W Meadows; Celia E Dominguez; Jessica B Spencer; Lyndsey A Darrow; Metrecia L Terrell; Michele Marcus
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

5.  Novel roles for hypoxia and prostaglandin E2 in the regulation of IL-8 during endometrial repair.

Authors:  Jacqueline A Maybin; Nikhil Hirani; Henry N Jabbour; Hilary O D Critchley
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

6.  The expression and regulation of adrenomedullin in the human endometrium: a candidate for endometrial repair.

Authors:  Jacqueline A Maybin; Sharon Battersby; Nikhil Hirani; Leonid L Nikitenko; Hilary O D Critchley; Henry N Jabbour
Journal:  Endocrinology       Date:  2011-05-10       Impact factor: 4.736

7.  The regulation of vascular endothelial growth factor by hypoxia and prostaglandin F₂α during human endometrial repair.

Authors:  Jacqueline A Maybin; Nikhil Hirani; Pamela Brown; Henry N Jabbour; Hilary O D Critchley
Journal:  J Clin Endocrinol Metab       Date:  2011-06-15       Impact factor: 5.958

8.  Effect of a hormone-releasing intrauterine system (Mirena(®)) on aromatase and Cox-2 expression in patients with adenomyosis submitted or not, to endometrial resection.

Authors:  Hugo Maia; Clarice Haddad; Julio Casoy; Rebeca Maia; Nathanael Pinheiro; Elsimar M Coutinho
Journal:  Int J Womens Health       Date:  2012-04-12

9.  The effect of oral contraceptives on aromatase and Cox-2 expression in the endometrium of patients with idiopathic menorrhagia or adenomyosis.

Authors:  Hugo Maia; Clarice Haddad; Nathaniel Pinheiro; Julio Casoy
Journal:  Int J Womens Health       Date:  2013-06-13

10.  A role for lipoxin A₄ as an anti-inflammatory mediator in the human endometrium.

Authors:  Linsay J Macdonald; Sheila C Boddy; Fiona C Denison; Kurt J Sales; Henry N Jabbour
Journal:  Reproduction       Date:  2011-05-09       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.